WiQo

What WiQo does

WiQo S.p.A. is an Italian dermocosmetic and medical device manufacturer headquartered in Milan with operations in Muggia (Trieste), specializing in non-invasive skin biorevitalization. The company's core technology is the patented PRX-T33 formulation, a needle-free topical treatment combining TCA, hydrogen peroxide, and kojic acid, now extended by the second-generation PRX-PLUS skin booster. These professional products are applied in-clinic by licensed dermatologists and aesthetic physicians, complemented by a branded line of homecare cosmeceuticals (including Lightening Serum, Restructuring Vitamin Cream, Smoothing Fluid, Nourishing Creams, ICP Cream, Balancing Cream, and Firming Body Cream) that together form the integrated PRX-Therapy protocol. The PRX-T33 treatment has been performed over 8 million times across 40,000+ dermatologists globally, with documented efficacy claims including reductions in hyperpigmentation (-36%), free-radical activity (-95%), wrinkle depth (-17%), and enlarged pores (-44%).

WiQo operates an exclusive physician-only distribution model, restricting professional product sales to licensed medical practitioners who access the catalog through the gated be.WiQo B2B platform. Distribution is supported by a hybrid of direct sales, doctor-led recommendations for homecare products, and regional distribution partners, including the March 2024 acquisition of Boston-based Love Beauty Pro & Medical to enter the US market directly. The company maintains localized commercial websites for France, Italy, India, the United States, Brazil, and several LATAM countries, and is privately held with private equity backing. The revenue model is built on one-time professional product purchases and recurring homecare cosmeceutical repurchases recommended by treating physicians.

The competitive position is anchored by international patents on PRX-T33 and PRX-PLUS, an established physician channel, and an integrated clinical-to-home protocol that creates dual-product adoption per treatment cycle. WiQo is classified as a private S.p.A. (Italian public limited company) operating in the aesthetic medicine industry, with regulatory restrictions explicitly excluding Italy, Greece, Poland, Spain, Sweden, Switzerland, Turkey, and UAE from its foreign-markets communications.

Name

WiQo

Legal name

WiQo S.p.A.

Website

https://wiqo.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

WiQo is an Italian dermocosmetic company that develops and sells the patented PRX-T33 and PRX-PLUS needle-free biorevitalization treatments, distributed exclusively to dermatologists and aesthetic physicians globally, with complementary homecare cosmeceuticals completing its integrated PRX-Therapy protocol.

Ownership category

akta.pro rank

Product category

Aesthetic Medicine Dermocosmetics

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)

Keywords

• Aesthetic medicine products
• Dermocosmetic manufacturing
• Skin biorevitalization
• Professional skincare
• Cosmeceutical products

Headquarters

HQ city

Muggia

HQ country

Italy

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations

Revenue model

1. Professional Products: WiQo sells professional-grade aesthetic treatments (PRX-T33, PRX-PLUS) exclusively to licensed doctors and healthcare professionals for in-clinic use. These patented formulations are applied during office visits.
2. Homecare Cosmeceuticals: Companion skincare products (Nourishing Creams, Smoothing Fluid, Lightening Serum, Restructuring Vitamin Cream, ICP Cream, Balancing Cream, Firming Body Cream) sold to consumers for continued at-home treatment following in-office procedures.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

WiQo manufactures and sells patented professional biorevitalization products (PRX-T33 and PRX-PLUS) used by dermatologists and aesthetic physicians for in-clinic, non-invasive skin treatments. The company complements these with a line of homecare cosmeceuticals (serums, creams, fluids, body cream) that support the integrated PRX-Therapy protocol for long-lasting skin renewal. Products are distributed exclusively through licensed healthcare professionals via the dedicated be.WiQo B2B platform.

Product overview

WiQo is a pioneer in aesthetic medicine combining scientific research and clinical expertise to develop innovative, science-backed dermo-medical solutions. The company offers a two-tier product architecture: Professional Products (PRX line) comprising PRX-T33 and PRX-PLUS for in-clinic treatments, and Homecare Cosmeceuticals including Lightening Serum, Restructuring Vitamin Cream, Smoothing Fluid, Nourishing Creams (for dry skin and normal/combination skin), ICP Cream, Balancing Cream, and Firming Body Cream. These work together through PRX-Therapy protocols, offering a complete non-invasive approach to visibly improve skin quality with no needles and no downtime.

Differentiator

Problem solved

Functional benefit

Brands

• PRX-T33: Non-invasive biorevitalization treatment combining TCA/H2O2/Kojic acid for skin rejuvenation without needles or downtime
• PRX-PLUS
• PRX-Therapy
• WiQo Professional Products
• WiQo Homecare Products
• be.WiQo

Quantifiable outcome

• 8 million+ PRX-T33 applications performed worldwide
• +9 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Love Beauty Pro & MedicalcoreChannel Partner/ Reseller/ Distributor · 27 March 2024WiQo expanded its US presence by acquiring Love Beauty Pro & Medical, a Boston-based company specializing in sales, marketing, distribution, and training in aesthetic medicine. The acquisition aims to strengthen WiQo's market share and elevate its reputation in the US aesthetic medicine sector, supported by private equity backing.

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Broad incumbents

• SkinCeuticals: SkinCeuticals (L'Oréal) is a leading medical-grade skincare brand sold through physicians and med-spas. Directly comparable to WiQo in channel strategy (doctor-dispensed), product positioning (science-backed actives), and target customer (aesthetic medicine practitioners and their patients).
• SkinMedica: SkinMedica (Allergan Aesthetics/AbbVie) is a physician-dispensed skincare brand focused on rejuvenation and anti-aging. Comparable to WiQo in its professional-channel-only distribution model and clinically-validated treatment/homecare positioning.
• Dermalogica: Dermalogica (Unilever) is a professional skincare brand sold through skin therapists and licensed professionals globally. Comparable to WiQo for its professional-channel model, although Dermalogica leans more toward skin therapists than physicians.

Direct peers

• Obagi Medical: Obagi Medical is a physician-dispensed medical-grade skincare brand known for transformative skin health systems including professional treatments and homecare regimens. Closely comparable to WiQo's PRX-Therapy model combining in-clinic procedures with daily-use products sold via doctors.
• Alastin Skincare: Alastin Skincare (Galderma) develops procedure-supporting skincare products sold through physicians and aesthetic practices. Highly comparable to WiQo for its focus on complementing in-office aesthetic procedures with clinically-tested topical products in the same channel.
• PCA Skin: PCA Skin is a professional skincare brand offering chemical peels and homecare products sold through licensed skincare professionals and physicians. Directly comparable to WiQo for professional treatments (including TCA-based peels) paired with homecare routines in a professional-only channel.
• iS Clinical: iS Clinical is a clinical skincare brand sold through physicians, spas, and licensed professionals with a focus on active-ingredient formulations for visible results. Comparable to WiQo for its professional channel strategy and clinically-tested cosmeceutical portfolio.
• Colorescience: Colorescience is a dermatologist-recommended skincare brand specializing in mineral-based sun protection and skin health products. Comparable to WiQo for physician-channel distribution and clinically-positioned homecare products.

Emerging players

• Neocutis: Neocutis (Merz Aesthetics) is a physician-dispensed skincare brand focused on anti-aging, post-procedure, and skin rejuvenation using growth factors and peptides. Comparable to WiQo for the doctor-channel-only model and rejuvenation-focused product portfolio.
• HydroPeptide: HydroPeptide is a professional skincare brand sold through spas, dermatologists, and licensed aestheticians, with a focus on peptide-driven anti-aging products. Comparable to WiQo for its professional-only distribution, clinical positioning, and emphasis on results-driven homecare regimens.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/gpq-srl
• Instagraminstagram.com/wiqo_official

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WiQo